Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab in Previously Untreated Follicular NHL
NCT01190449Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2011
- Primary completion
- Mar 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in follicular lymphoma (FL), sponsored by Cancer and Leukemia Group B. Started Aug 2011; status: completed.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01190449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190449.